MinervaX

Last updated: May 02, 2024

Founder Per Fischer
Founder Per Fischer
Country: Denmark | Funding: $215.5M (+)

Website: http://minervax.com/

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.